These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 445370)

  • 1. Urinary nonesterified cholesterol excretion in adenocarcinoma of the prostate.
    Belis JA; Cenedella RJ
    Cancer; 1979 May; 43(5):1840-6. PubMed ID: 445370
    [No Abstract]   [Full Text] [Related]  

  • 2. Urinary cholesterol excretion in men with benign prostatic hyperplasia and carcinoma of the prostate.
    Juengst D; Pickel A; Elsaesser E; Marx FJ; Karl HJ
    Cancer; 1979 Jan; 43(1):353-9. PubMed ID: 83906
    [No Abstract]   [Full Text] [Related]  

  • 3. Urinary cholesterol. V. Its excretion in men with testicular and prostatic neoplasms.
    Acevedo HF; Campbell EA; Saier EL; Frich JC; Merkow LP; Hayeslip DW; Bartok SP; Grauer RC; Hamilton JL
    Cancer; 1973 Jul; 32(1):196-205. PubMed ID: 4123791
    [No Abstract]   [Full Text] [Related]  

  • 4. [Urinary excretion of cholesterol in various diseases. (Especially in cancer of the urogenital system)].
    Spiteller-Friedmann M; Spiteller G; Spiteller H; Frick J
    Osterr Z Erforsch Bekampf Krebskr; 1971; 26(1):25-35. PubMed ID: 5171242
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cholesterol and urinary tract diseases].
    Frick J; Spiteller G
    Z Urol Nephrol; 1968 Dec; 61(12):833-8. PubMed ID: 4183283
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostatic acid phosphatase levels. Significance in serum and bone marrow.
    Marshall S; Lyon RP; Scott MP
    Urology; 1974 Oct; 4(4):435-8. PubMed ID: 4424449
    [No Abstract]   [Full Text] [Related]  

  • 7. Bone marrow calcium in cancer of prostate and bladder.
    Megalli MR; Gursel E; Rudin L; Veenema RJ
    Urology; 1973 Jul; 2(1):25-7. PubMed ID: 4128960
    [No Abstract]   [Full Text] [Related]  

  • 8. [Acid phosphatase in the bone marrow: diagnostic value in prostatic carcinoma].
    Tenaillon M; Billon B; Kelly A; Toppercer A; Elhilali MM
    J Urol (Paris); 1980; 86(2):107-10. PubMed ID: 7452042
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnostic use of bone marrow acid and alkaline phosphatases.
    Yesus YW; Taylor HM
    Am J Clin Pathol; 1977 Jul; 68(1):92-3. PubMed ID: 868812
    [No Abstract]   [Full Text] [Related]  

  • 10. [New prospective diagnostic serum markers in prostatic cancer].
    Mirone V; De Bellis G; Prezioso D; Sanseverino R; Iannucci F; Padulano P
    Minerva Med; 1986 Mar; 77(13):503-4. PubMed ID: 2422605
    [No Abstract]   [Full Text] [Related]  

  • 11. Bone marrow acid phosphatase by radioimmunoassay.
    Belville WD; Cox HD; Mahan DE; Olmert JP; Mittemeyer BT; Bruce AW
    Cancer; 1978 Jun; 41(6):2286-91. PubMed ID: 77719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased acid phosphatase activity in prostate secretion associated with prostatic carcinoma.
    Mourad WA; Straumfjord JV; Persky L; Helal MA; Foulis PR
    Clin Chem; 1990 Aug; 36(8 Pt 1):1517. PubMed ID: 2387049
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative evaluation of serum acid phosphatase, urinary cholesterol, and androgens in diagnosis of prostatic cancer.
    Chu TM; Shukla SK; Mittelman A; Murphy GP
    Urology; 1975 Sep; 6(3):291-4. PubMed ID: 1162806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of prostatic acid phosphatase in the investigation and treatment of adenocarcinoma of the prostate.
    Bruce AW; Mahan DE
    Ann N Y Acad Sci; 1982; 390():110-21. PubMed ID: 6953923
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostatic cancer. Immunochemical detection of prostatic acid phosphatase in serum and bone marrow.
    Catane R; Madajewicz S; Wajsman ZL; Chu TM; Mittelman A; Murphy GP
    N Y State J Med; 1978 Jun; 78(7):1060-1. PubMed ID: 275612
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prostatic cancer. Reliability of clinical staging and the prognostic significance of age, clinical stage and tumor morphology].
    Mihatsch MJ; Rist M; Ohnacker H; Oberholzer M; Spichtin HP; Schmassmann A; Perret A; Torhorst J; Rutishauser G
    Z Urol Nephrol; 1983 May; 76(5):281-97. PubMed ID: 6880416
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the clinical significance of nonesterified and total cholesterol in urine.
    Jüngst D; Wallner J; Pickel A; Stadler A; Eiermann W; Marx FJ; Karl HJ
    Klin Wochenschr; 1981 Jun; 59(11):545-52. PubMed ID: 6167760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New diagnostic use of bone marrow acid and alkaline phosphatase.
    Yarrison G; Mertens BF; Mathies JC
    Am J Clin Pathol; 1976 Oct; 66(4):667-71. PubMed ID: 970368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of chyluria secondary to advanced carcinoma of the prostate.
    Cluskey SA; Myatt A; Ferro MA
    Prostate Cancer Prostatic Dis; 2008; 11(1):102-5. PubMed ID: 17667966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenocarcinoma of the prostate gland.
    Boxer RJ
    Urol Surv; 1977 Jun; 27(3):75-94. PubMed ID: 331648
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.